- RecruitingPHASE1, PHASE2
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
This study is testing a new, one-time eye injection for people with Geographic Atrophy (GA), a severe form of age-related macular degeneration (AMD). Researchers want to see if it's safe and helps improve or maintain vision. It involves a single treatment followed by long-term check-ups.
For: Geographic AtrophyUnited States · Australia · United Kingdom - RecruitingPHASE3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
This study, called Proact, is investigating a new treatment called REACT (also known as rilparencel) for people with type 2 diabetes and chronic kidney disease. Researchers want to see if this treatment can help kidney function and if it is safe.
For: Type 2 Diabetes Mellitus · Chronic Kidney DiseasesUnited States · Australia · Canada - RecruitingPHASE3
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
This study is testing a new medicine, zorevunersen, for children and teenagers with Dravet syndrome. We want to see if it can help reduce seizures and improve their overall health, using a safe and gentle approach.
For: Dravet SyndromeUnited States · China · France